Krishna Ella, chairman and managing director of Bharat Biotech, said the peer review in The Lancet, an authoritative voice in global medicine, validated their commitment to data transparency and meeting the stringent peer review standards of leading medical journals. After the World Health Organisation’s emergency use listing to Covaxin, vaccine maker Bharat Biotech received a … Read more
World Health Organization approved Covaxin for use among people aged 18 years and above Bharat Biotech’s Covaxin demonstrates 77.8 per cent efficacy against symptomatic Covid-19, peer-reviewed general medical journal The Lancet confirmed. As per phase-three clinical trials data, Covaxin is also the only Covid-19 vaccine that has demonstrated efficacy data against delta variant at 65.2 … Read more
Covaxin has not been granted permission to be used without restriction, even as Bharat Biotech had sought complete authorisation. Covaxin efficacy: Data from the phase 3 trials of Bharat Biotech’s Covaxin – India’s only indigenous coronavirus vaccine so far – has been shared by the manufacturer, and it shows that symptomatic COVID-19 cases can be … Read more
“My deep appreciation to all the volunteers for reposing trust and expressing Pro Vaccine Public Health Volunteerism in Phase 3 clinical Trial of India’s first fully indigenous Covid-19 vaccine. Thank You India,” Suchitra Ella, Joint Managing Director, Bharat Biotech International Limited said. Bharat Biotech has successfully completed the enrolment of 25,800 volunteers for Phase 3 … Read more
Covaxin news, update: On January 3, the Ministry of Health and Family Welfare announced that Emergency Use Authorization (EUA) has been granted to Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin. With approvals of two Covid-19 vaccines—Covaxin (Bharat Biotech) and Covishield (Serum Institute-Oxford), India is all set to begin one of the world’s biggest … Read more
Covid-19 vaccine rollout in India: Management of any possible adverse events following immunization (AEFI) has been taken care of. (Reuters image) As India formally approved two Covid-19 vaccines—Covaxin and Covishield—for emergency use, the focus has now shifted to what next for Covid-19 vaccines rollout in the country! With the two Covid-19 vaccines of Bharat Biotech … Read more
The Phase III efficacy trial of Covaxin was initiated in India in 25,800 volunteers and till date, around 22,500 participants have been vaccinated across the country and the vaccine has been found to be safe as per the data available till date, the Ministry of Health and Family Welfare said in a statement. Covid vaccine … Read more